Navigation Links
Assessment of safety and efficacy of human embryonic stem cell therapy
Date:6/12/2009

Worcester, MA June 11, 2009 (EurekAlert)--Advanced Cell Technology, Inc. (OTC:ACTC.PK) and its collaborators at OHSU reported today the long-term safety and efficacy of human embryonic stem cell (hESC)-derived retinal pigment epithelium (RPE) produced under manufacturing conditions suitable for human clinical trials. Two important early potential hESC applications are the use of RPE for the treatment of age-related macular degeneration and Stargardt disease, an untreatable form of eye disease that leads to early-onset blindness. The research, which appears online ahead of print in the journal Stem Cells, shows long-term functional rescue using hESC-derived cells in both the RCS rat and Elov14 mouse, animal models of retinal degeneration and Stargardt, respectively. The cells survived transplantation for prolonged periods (>220 days) and sustained visual function without tumor formation or untoward pathological reactions. Near-normal functional rescue was also achieved in the 'Stargardt' mouse. To further address safety concerns, a study was carried out in the NIH III immune deficient mouse model. Long-term data (spanning the life of the animals) revealed no evidence of tumor formation after transplantation.

"We're delighted with these results," said Robert Lanza, Chief Scientific Officer at ACT, and co-senior author of the study. "Everything looks great so far. Based on these and other studies, we're on schedule to file an IND with the FDA to begin human clinical trials sometime in the next 3 or 4 months. Barring any surprises, Stargardt disease and macular degeneration are likely to be the next two clinical applications of ES technology.

Since their discovery over a decade ago, hESCs have been considered a promising source of replacement cells for clinical studies. However, problems continue to plague clinical translation, including the risk of teratoma formation and the need for powerful drugs to overcome the problem of immune
'/>"/>

Contact: Kathy Singh
ksingh@advancedcell.com
508-756-1212 x653
Advanced Cell Technology
Source:Eurekalert

0

GOOD

Page: 1 2 3

Related biology technology :

1. Serial Monitoring With ImmuKnow(R) is Useful in the Risk Assessment of Kidney Transplant Recipients
2. PDHI Launches Short Form of Its ConXus Profile Health Assessment
3. The Coalition to Prevent Deep-Vein Thrombosis (DVT) RV Tour Takes to the Road to Educate the Nation About the Importance of DVT Risk Assessment
4. New Program Offers Breast Cancer Clinicians and Patients Support for Pre-Operative Clinical Assessment and Ongoing Surveillance of Lymphedema
5. 4C Controls Announces the Appointment of Dr. Philip Hayden as Vice President, Security Assessment & Threat Analysis
6. United BioSource Corporation and CogState Ltd. Form Strategic Partnership to Support Cognitive Assessment in Clinical Research
7. VAP(R) Cholesterol Test Bolsters Biophysical(R) Health Assessment
8. Simbionix Releases Powerful New Learning Management System With Enhanced True Assessment System(TM)
9. OncoGenex receives completed Special Protocol Assessment for primary registration study of lead drug candidate OGX-011
10. Follow-up Phone Surveys: Effective Customer Service Assessment Tool for Improving Satisfaction
11. Expert Consensus Panel Recommendation for Incorporating Lp-PLA2 Testing into Cardiovascular Disease Risk Assessment Guidelines

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...able in German . , Whether it,s CD packagin...Radio Frequency Identification) are increasingly f...possible to label objects or goods and identify th...te scanner can read and process the data contained...s under production conditions of up to 100 degrees...
(Date:11/24/2009)...,Nov.24/PRNewswire/--Twomoreprestigiousuniversitie...ejobboardandcareerssiteforlifescienceprofessionals...bersofthejobboard,joining28othermajorlifesciencetr...ercenter.com ,isonlyforpost-graduatesinthelifescie...ontheInternet,BioCareerCenteristheonlyonethatserve...
(Date:11/24/2009)... Health care employment grew by 29,000 jobs in ...w consistent growth during the U.S. recession. How...ouble, and health systems are coming closer to hav...just administrators. , (V...continued growing in October despite the shedding ...
(Date:11/24/2009)...PRNewswire-Asia/--ShanghaiBiolaxyannouncedthe,Chin...edthe,investigationalnewdrugapplication(IND)forits...mulationtotreatdiabetes.ThisIND,approvalallowsBiol...iabetesisadisordercharacteristicofhighbloodglucose...resultinseveremicro-and,macro-vasculardiseases,los...
Breaking Biology Technology:Intelligence inside metal components 2Two Major Universities Join Nation's Leading Postgrad Bio Job Board 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4Biolaxy Secures IND Approval for Oral Insulin 2
...urocrine Biosciences,Inc. (Nasdaq: NBIX ) announc...loyees at its San Diego campus, as a part of its r...d development programs and associated costs,and ex...ese reductions,Neurocrine will have approximately ...that we have to make this difficult,decision that ...
... Martek Biosciences,Corporation announced today t...icense and supply agreement for infant formula wit...harmaceutical. Under the terms of the,agreement, M... all IlDong,Foodis infant formula products in Sout...at contain the long-chain,polyunsaturated fatty ac...
...he US Oncology Adjuvant Trial 9735 at 2007 San, A...and Cyclophosphamide Improved Overall Survival..., Dec. 13 Results presented at the,30th annual Sa...hat for,women with early stage breast cancer who h...l chemotherapy combination of Taxotere(R) (docetax...
Other Biology Technology:Neurocrine Announces Work Force Restructuring 2Neurocrine Announces Work Force Restructuring 3Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea 2Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 2Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 3Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 4Taxotere(R)-Based Chemotherapy Significantly Improved Overall Survival Compared With Standard Anthracycline-Based Chemotherapy in Early Stage Breast Cancer 5
(Date:11/23/2009)...t a common oral bacterium may exacerbate autoimmun...Unique Lipids from a Common Human Bacterium Repres...ng Autoimmunity," appears in the December 2009 iss...tiple sclerosis (MS), a disease where the immune s...early 1 in 700 people in the United States. Patie...
(Date:11/23/2009)...highest resolution images of peptides attaching to...tanding how biomolecules manipulate the growth cry...or kidney stones using biomolecules. , The resea...f the journal Proceedings of the National Academy... mineral surfaces by accelerating, switching and i...
(Date:11/23/2009)...icrobiologist Louis Tisa has received two grants t...ctinorhizal plants, widespread woody plants with p...soils. , The United States Department of Agricu...r, cellular and biomedical sciences, $399,000 to e...eria Frankia and Casuarina, an actinorhizal plant....
Breaking Biology News(10 mins):Factors from common human bacteria may trigger multiple sclerosis 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 2Scientists watch as peptides control crystal growth with 'switches, throttles and brakes' 3UNH prof. receives nearly $500,000 to research environmentally significant plants 2Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12484 1Poniard Pharmaceuticals to Present at the 8th Annual Needham Life Sciences Conference 12484 2Baylor Dallas Opens Nations First Neurosurgical OR Suite Featuring BrainSUITE iMRI GE Healthcare MR Surgical Technology 48035 1Baylor Dallas Opens Nations First Neurosurgical OR Suite Featuring BrainSUITE iMRI GE Healthcare MR Surgical Technology 48035 2Isis Pharmaceuticals to Present at Needhams 8th Annual Life Sciences Conference 48033 1
...on evolution will gather in Minnesota June 20 thro...nnual gathering of evolutionary biologists. The co...ntists to share research related to evolution, is ...seum of Natural History, the university,s College ...Science Education. , Headlining the event is Oliv...
...ounded evolutionary biologists since Charles Darwi...e parasites depend on their hosts for survival, wh...a and Emory University study of monarch butterflie...on them finds that the parasites strike a middle g...apidly and the costs to their hosts. The study, pu...
...holtz Centre for Environmental Research (UFZ) in L...(Caltech) in Pasadena succeeded in capturing syntr...at are known to dramatically reduce the oceanic em...organisms that oxidize methane anaerobically are a...nd a major sink for methane on Earth. Methane -- a...
Other Biology News:University of Minnesota to host world's largest conference on evolution 2Monarch butterflies help explain why parasites harm hosts 2Monarch butterflies help explain why parasites harm hosts 3Deep sea methane scavengers captured 2Deep sea methane scavengers captured 3
Mouse Anti-MMP-20 Monoclonal Antibody, Unconjugated, Clone MMP2/2C1 from ABR-Affinity BioReagents
Rabbit Anti-T-box 6 Monoclonal Antibody, Unconjugated, Clone PADZMD.501 from Invitrogen
RSK2 siRNA siAb™ Assay Kit from Upstate
TriContinentMultiWash III from Femto Scientific
Biology Products: